相关实验视频

Updated: Jul 8, 2026

Preparation of Herbal Medicine: Er-Xian Decoction and Er-Xian-containing Serum for In Vivo and In Vitro Experiments
08:07

Preparation of Herbal Medicine: Er-Xian Decoction and Er-Xian-containing Serum for In Vivo and In Vitro Experiments

Published on: May 31, 2017

11.0K

中国草本提取物调节动脉样硬化相关信号通路:最近的证据和观点

Changxing Liu1, Xinyi Guo2, Xulong Zhang3

  • 1Heilongjiang University of Chinese Medicine, Harbin, China.

Phytotherapy research : PTR
|April 5, 2024
PubMed
概括

动脉样硬化是心脏病的主要原因,涉及复杂的信号通路. 传统中医 (TCM) 通过调节这些途径,提供有希望的,更安全的治疗方法,有助于心血管疾病管理.

关键词:
中国医学中医药是什么?有效成分 活性成分 有效成分动脉样硬化 动脉样硬化这些机制的机制.审查 审查 审查 审查 审查 审查

更多相关视频

Preparation Of Gushukang GSK Granules for In Vivo and In Vitro Experiments06:16

Preparation Of Gushukang GSK Granules for In Vivo and In Vitro Experiments

Published on: May 9, 2019

7.6K
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

563

相关概念视频

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...